Life-Sciences-Benelux.com
The Benelux Life Sciences Web Portal

This is a free web portal for the life sciences in Belgium, The Netherlands and Luxembourg... » read more

DeuterOncology Closes €5.65m Series A Financing Round (2023-01-19)
Belgian biotech company will use funding to start first-in-human clinical study for lead drug candidate in lung cancer DeuterOncology, a clinical-stage drug development company, today announces the closing of its €5.65 million ($6.1M) Series A financing, with ...
BGV: Jaap de Bruin Joins & Rianne Ellenbroek Promoted (2023-01-17)
BioGeneration Ventures (“BGV”), a leading early-stage VC in European biopharma, today announces the appointment of Jaap de Bruin as Investment Manager, leading BGV’s Fonds InvesteringsRijpe Starters (FIRST) fund, taking over from Rianne Ellenbroek who is promoted t...
Qiagen Launches EZ2 Connect MDx Platform for Dx Labs (2023-01-17)
> Start of worldwide diagnostic use follows the launch of upgraded EZ2 Connect for research use in 2021, builds on the success of EZ1 Connect platform found in thousands of labs worldwide > EZ2 Connect MDx puts standardized, efficient nucleic acid purification i...
AstraZeneca Completes up to $320m Acquisition of Neogene (2023-01-16)
AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, develoldpment and manufacturing of next-generation T-cell receptor therapies (TCR-Ts). Neogene will operate ...
CureVac Appoints Alexander Zehnder as CEO, Joins from Sanofi (2023-01-10)
> Dr. Franz-Werner Haas to complete successful tenure as CEO by March 31, 2023 > Dr. Alexander Zehnder to succeed Dr. Haas as new CEO, joining from Sanofi on April 1, 2023 CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new clas...
Qiagen Completes $150m Cash Acquisition of Verogen (2023-01-09)
> Verogen a proven leader in equipping forensic science laboratories and criminal investigators to use next-generation sequencing (NGS) to gain deeper insights > Addition of Verogen strengthens QIAGEN leadership in fast-growing field of Human ID / forensics anch...
ExeVir Receives €25m Venture Debt Financing from EIB (2023-01-09)
> ExeVir signs €25 million venture debt financing with European Investment Bank to develop a llama-derived nanobody COVID-19 therapeutic, labelled XVR012. > Project expected to have important public health impact, addressing underserved therapeutics market for im...
Volta Medical Raises €36m Series B Led by Vensana Capital (2023-01-05)
> New round of financing led by Vensana Capital will support technology platform expansion and further validating VX1, Volta’s Artificial Intelligence (AI) Decision-Support Software in improving catheter ablation for complex cardiac arrhythmias > Medical device ...
Hummingbird Licenses Synaffix’ ADC Technologies; up to $150m (2023-01-04)
> Synaffix to provide Hummingbird Bioscience access to proprietary ADC technologies > Synaffix to receive up to $150m in upfront and milestone payments plus royalties Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical...
EIB Lends €20m to Affibody AB for Biopharma Development (2022-12-23)
> The EIB will provide a €20 million loan to Swedish biopharmaceutical company Affibody. > The EIB loan will finance the research and development of next-generation biopharmaceuticals against cancer and inflammatory diseases. > This agreement is supported by ...

Life-Sciences-Benelux.com is your doorway to the Benelux life sciences!

[LSBNL] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Benelux countries Belgium, The Netherlands and Luxembourg.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSBNL] is 100% Made in Germany!

» Start here with the latest News!

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)